Chapter 27 Monitoring the Pregnant Mare

  1. Bucca S: Ultrasonographic monitoring of the fetus. In McKinnon AO, Squires EL, Vaala WE, Varner DD, editors: Equine reproduction, ed 2, Ames, Iowa, 2011, Wiley-Blackwell, pp 39-54.
  2. Daels PF, Mohammed HO, Odensvik K et al: Effect of flunixin meglumine on endogenous prostaglandin F2α secretion during cloprostenol-induced abortion in mares, Am J Vet Res 56:1603-1610, 1995. PUBMED Abstract
  3. Daels PF, Besognet B, Hansen B et al: Effect of progesterone on prostaglandin F2α secretion and outcome of pregnancy during cloprostenol-induced abortion in mares, Am J Vet Res 57:1331-1337, 1996. PUBMED Abstract
  4. Inan C, Kilic I, Kilinc K et al: The effect of high dose antenatal vitamin E on hypoxia-induced changes in newborn rats, Pediatr Res 38:685-689, 1995. PUBMED Abstract
  5. LeBlanc MM: Ascending placentitis in the mare: an update, Reprod Domest Anim 45(Suppl 2):28-34, 2010. PUBMED Abstract
  6. McCue PM, McKinnon AO: Pregnancy examination. In McKinnon AO, Squires EL, Vaala WE, Varner DD, editors: Equine reproduction, ed 2, Ames, Iowa, 2011, Wiley-Blackwell, pp 2245-2261.
  7. Neuhauser S, Palm F, Ambuehl F et al: Pregnancy on parturition and on neonatal viability of their foals, Exp Clin Endocrinol Diabetes 116:423-428, 2008.
  8. Ousey JC: Hormone profiles and treatments in the late pregnant mare, Vet Clin North Am Equine Pract 22:727-747, 2006. PUBMED Abstract
  9. Paccamonti DL: Milk electrolytes and induction of parturition, Pferdeheilkunde 17:616-618, 2001.
  10. Palmer E, Chavatte-Palmer P, Duchamp G et al: Lack of effect of clenbuterol for delaying parturition in late pregnant mares, Theriogenology 58:797-799, 2002.
  11. Palmer Jon: Fetal monitoring. Proceedings of the Society for Theriogenology, Nov 28-Dec 2, 2000, San Antonio, TX.
  12. Plumb DC: Plumb’s veterinary drug handbook, ed 7, Ames, Iowa, 2011, Wiley-Blackwell.
  13. Reef VB: Equine diagnostic ultrasound, Philadelphia, 1998, WB Saunders.
  14. Riddle WT: Preparation of the mare for normal parturition. Proceedings of the 49th Annual Convention of the AAEP, November 21-25, 2003, New Orleans, LA.
  15. Ryan PL, Christiansen DL, Hopper RM et al: Evaluation of systemic relaxin blood profiles in horses as a means of assessing placental function in high-risk pregnancies and responsiveness to therapeutic strategies. Relaxin and Related Peptides: Fifth International Conference, Ann N Y Acad Sci 1160:169-178, 2009. PUBMED Abstract
  16. Santschi EM, Vaala WE: Management of the high-risk pregnancy. In McKinnon AO, Squires EL, Vaala WE, Varner DD, editors: Equine reproduction, ed 2, Ames, Iowa, 2011, Wiley-Blackwell, pp 25-38.
  17. Troedsson MHT: High risk pregnant mare, Acta Veterinaria Scandinavica 49(Suppl 1): S9, 2007.
  18. Troedsson MHT, Renaudin CD, Zent WW et al: Transrectal ultrasonography of the placenta in normal mares and mares with pending abortion: a field study. Proceedings of the 43rd Annual Convention of the American Association of Equine Practitioners, December 7-10, 1997, Phoenix, Arizona.
  19. Vaala WE: Monitoring the high-risk pregnancy. In McKinnon AO, Squires EL, Vaala WE, Varner DD, editors: Equine reproduction, ed 2, Ames, Iowa, 2011, Wiley-Blackwell, pp 16-24.
  20. Vanderwall DK, Marquardt JL, Woods GL: Use of a compounded long-acting progesterone formulation for equine pregnancy maintenance, J Equine Vet Sci 27:62-66, 2007.
  21. Wilkins PA: Monitoring the pregnant mare in the ICU, Clin Tech Equine Pract 2:212-219, 2003.